University of Wisconsin–Madison

Category: Megan Piper

Alex finds Avenues to quit smoking

Alex had smoked for 29 years and had tried vaping on and off for a year. He attempted to quit several times – including going cold turkey, taking bupropion and even hypnosis. None of it held. Then he tried the Avenues study. Avenues offers help to those who both smoke and vape to either quit …

UW-CTRI helps optimize research

UW-CTRI Research Director Dr. Megan Piper joined many collaborators and peers in Washington, D.C. for the 2026 Conference on Intervention Optimization, hosted by Dr. Linda Collins. Collins credited UW-CTRI founders Dr. Tim Baker and Dr. Michael Fiore for implementing her factorial designs and helping to implement the strategy in the real world. Piper was the …

UW-CTRI takes Wisconsin Idea to Baltimore

UW-CTRI colleagues presented and served in a plethora of roles at the Society for Research on Nicotine and Tobacco (SRNT) 2026 Annual Conference in Baltimore. Here is a rundown: Pre-conference workshops UW-CTRI Researcher Dr. Jesse Kaye and Dr. Andrea Weinberger were workshop co-chairs for “Tobacco and Cannabis Co–Use Through a Health Equity Lens.” At that …

UW-CTRI media round-up

Whoo-wee, did UW-CTRI lasso some publicity by granting interviews with big media partners. So wrangle a saddle and check it out!

Avenues study goes national

For people who both smoke and vape, there will be new paths to help them address their relationship with nicotine – now from coast to coast. The Avenues study has expanded to recruit nationally, thanks to funding from the National Cancer Institute. UW-CTRI Research Director Dr. Megan Piper and UW-CTRI Associate Director Dr. Tim Baker lead the study, with …

WSHS 2 data spurs methodological innovations

Data from a UW-CTRI study known as the Wisconsin Smokers’ Health Study 2 has helped colleagues from other methodology centers and UW-CTRI to develop a variety of methodological innovations. The latest novel approach was recently published in the journal Multivariate Behavioral Research. In longitudinal studies, exposure to treatment and mediators (factors influenced by treatment) rarely stay constant. For …

Wisconsin Idea to Shine in Baltimore

UW-CTRI colleagues will embody the Wisconsin Idea by presenting their research findings to people from around the world during the Society for Research on Nicotine and Tobacco’s 2026 annual conference in Baltimore. Here is a run-down of the honors and presentations: Dr. Adrienne Johnson will begin her role as the new SRNT Treasurer. Dr. Megan …

Test deciphers whether a patient really smoked, vaped or both

Researchers published a paper in Nicotine & Tobacco Research about a novel way to test whether a patient has used just vaping products, just smoking products or both within the last 48 hours. The research, led by Alma Nieto at the CDC, tested the ability of two biomarkers—2CyEMA, a marker of smoke exposure, and cotinine, …

Research gaps remain in co-use of cannabis and tobacco

UW-CTRI Research Director Dr. Megan Piper and UW-CTRI Director Dr. Hasmeena Kathuria served on the American Thoracic Society expert panel who reviewed the latest evidence on co-use of cannabis and tobacco and made several important recommendations. Kathuria served as the chair, Piper as a co-chair. “There’s a lot we don’t know about what happens when people use tobacco and …

Avenues study goes national

For people who both smoke and vape, there will be new paths to help them address their relationship with nicotine – now from coast to coast. The Avenues study has expanded to recruit nationally, thanks to funding from the National Cancer Institute. In just two hours recruiting via social media, the team had generated 354 …